The wearable cardioverter-defibrillator is an established technology for patients at high arrhythmic risk with reversible causes or awaiting an ICD, as recognized by the 2015 ESC guidelines.
The wearable cardioverter-defibrillator has been available for over a decade and now is frequently prescribed for patients deemed at high arrhythmic risk in whom the underlying pathology is potentially reversible or who are awaiting an implantable cardioverter-defibrillator. The use of the wearable cardioverter-defibrillator is included in the new 2015 ESC guidelines for the management of ventricular arrhythmias and prevention of sudden cardiac death. The present review provides insight into the current technology and an overview of this approach.
Reek et al. (Tue,) studied this question.